Overview
| HCRTR1 | |
|---|---|
| Symbol | HCRT1 |
| Full Name | HCRTR1 |
| Type | Gene |
| NCBI | Search NCBI |
The HCRT1 (Hypocretin/Orexin 1) gene encodes the orexin-A neuropeptide, a critical regulator of arousal, wakefulness, and energy homeostasis. Formerly known as hypocretin-1, orexin-A is produced by a small population of neurons in the lateral hypothalamus and plays essential roles in sleep-wake regulation, reward processing, and metabolic function.
Pathway Diagram
flowchart TD
HCRTR1["HCRTR1"]
Sleep_Wake_Transition["Sleep-Wake Transition"]
HCRTR1 -->|"associated with"| Sleep_Wake_Transition
BDNF["BDNF"]
HCRTR1 -.->|"inhibits"| BDNF
cognitive_dysfunction["cognitive dysfunction"]
HCRTR1 -->|"promotes"| cognitive_dysfunction
Hemodynamic_Stability["Hemodynamic Stability"]
HCRTR1 -->|"associated with"| Hemodynamic_Stability
lactate_production["lactate production"]
HCRTR1 -.->|"inhibits"| lactate_production
Time_To_Loss_Of_Consciousness["Time To Loss Of Consciousness"]
HCRTR1 -->|"associated with"| Time_To_Loss_Of_Consciousness
Time_To_Wake["Time To Wake"]
HCRTR1 -->|"associated with"| Time_To_Wake
Propofol["Propofol"]
HCRTR1 -->|"interacts with"| Propofol
h_9e9fee95["h-9e9fee95"]
h_9e9fee95 -->|"therapeutic_target"| HCRTR1
style HCRTR1 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style Sleep_Wake_Transition fill:#e65100,stroke:#ff8a65,color:#ff8a65
style BDNF fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style cognitive_dysfunction fill:#880e4f,stroke:#f48fb1,color:#f48fb1
style Hemodynamic_Stability fill:#880e4f,stroke:#f48fb1,color:#f48fb1
style lactate_production fill:#e65100,stroke:#ff8a65,color:#ff8a65
style Time_To_Loss_Of_Consciousness fill:#880e4f,stroke:#f48fb1,color:#f48fb1
style Time_To_Wake fill:#880e4f,stroke:#f48fb1,color:#f48fb1
style Propofol fill:#1b5e20,stroke:#81c784,color:#81c784
style h_9e9fee95 fill:#263238,stroke:#90a4ae,color:#90a4aeKnowledge graph relationships for HCRTR1 (293 total edges in KG)
Gene and Protein Structure
The HCRT gene encodes a pre-pro-orexin precursor that is cleaved to produce two neuropeptides:
-
Orexin-A (Hypocretin-1): A 33-amino acid peptide with two disulfide bonds1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference
-
Orexin-B (Hypocretin-2): A 28-amino acid linear peptide1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference
These peptides bind to two G-protein coupled receptors:
-
OX1R (HCRTR1): Preferentially binds orexin-A2Narcolepsy in orexin knockout mice: molecular genetics of sleep regulationOpen reference
-
OX2R (HCRTR2): Binds both orexin-A and orexin-B2Narcolepsy in orexin knockout mice: molecular genetics of sleep regulationOpen reference
Normal Physiological Functions
Sleep-Wake Regulation
Orexin neurons form a critical wake-promoting system in the brain. These neurons are active during wakefulness, particularly during active exploration and reward-seeking behavior, and become silent during sleep. The orexin system helps maintain arousal, prevent sleep onset, and regulate sleep-wake transitions1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference3Sleep state switchingOpen reference.
Energy Homeostasis
Orexin neurons integrate metabolic signals (leptin, ghrelin, glucose) to regulate feeding behavior and energy expenditure. Activation of orexin neurons promotes food-seeking behavior and increases metabolic rate4To eat or to sleep? Orexin in the regulation of feeding and wakefulnessOpen reference.
Reward and Motivation
The orexin system projects to reward-related brain regions (VTA, NAc, lateral septum) and modulates dopamine-mediated reward processing. Orexin is involved in drug-seeking behavior and addiction5Orexin/hypocretin and reward: role of the orexin system in cocaine-seekingOpen reference.
Role in Neurodegeneration
Parkinson’s Disease
Sleep disorders, particularly REM sleep behavior disorder (RBD), are common early markers of Parkinson’s disease (PD). Remarkably, orexin neuron loss has been documented in PD patients, with studies showing a 40-50% reduction in orexin-producing neurons in the lateral hypothalamus6Hypocretin (orexin) loss in Parkinson's diseaseOpen reference. This loss correlates with:
-
Excessive daytime sleepiness in PD patients
-
Motor symptom severity
-
Disease progression
The degeneration of orexin neurons may contribute to the sleep disturbances and autonomic dysfunction seen in PD6Hypocretin (orexin) loss in Parkinson's diseaseOpen reference1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference0.
Alzheimer’s Disease
Orexin dysregulation has been implicated in the sleep disturbances characteristic of Alzheimer’s disease (AD). Elevated orexin-A levels have been found in the CSF of AD patients, potentially reflecting compensatory mechanisms or circadian rhythm disruption1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference1. Sleep fragmentation and altered orexin signaling may:
-
Accelerate amyloid-beta deposition
-
Impair memory consolidation
-
Contribute to the circadian disturbances seen in AD1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference2
Multiple System Atrophy (MSA)
MSA patients show significant orexin neuron loss, even more pronounced than in PD. This loss correlates with autonomic dysfunction and disease severity1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference3.
Expression Patterns
Orexin neurons are localized primarily in:
-
Lateral hypothalamus (perifornical area)
-
Dorsomedial hypothalamus
These neurons project widely to:
Therapeutic Implications
The orexin system represents a therapeutic target for neurodegenerative diseases:
-
Orexin receptor agonists: Dual orexin receptor agonists (e.g., lemborexant, suvorexant) are approved for insomnia and may help normalize sleep in ND patients1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference4
-
Orexin neuron protection: Neuroprotective strategies targeting orexin neurons may slow PD progression1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference5
-
Circadian alignment: Agents that restore orexin rhythmicity could improve sleep and cognitive function in AD1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference6
Key Research Findings
-
Narcolepsy is caused by orexin neuron loss, highlighting the peptide’s essential role in arousal1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference7
-
Orexin-A modulates amyloid-beta toxicity in neuronal cell models1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference8
-
Orexin receptor antagonists improve sleep in neurodegenerative disease mouse models1The neural circuit of orexin (hypocretin): maintaining sleep and wakefulnessOpen reference9
See Also
Brain Atlas Resources
Allen Brain Atlas
-
Allen Human Brain Atlas - Gene expression data
-
Allen Mouse Brain Atlas - Mouse brain gene expression
-
BrainSpan Atlas - Developmental transcriptome data
Related Resources
-
Allen Cell Type Atlas - Cell type-specific expression
-
Allen Institute Data Portal - Neuroscience data resources
References
- The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
- Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation
- Sleep state switching
- To eat or to sleep? Orexin in the regulation of feeding and wakefulness
- Orexin/hypocretin and reward: role of the orexin system in cocaine-seeking
- Hypocretin (orexin) loss in Parkinson's disease
- Reduced number of hypocretin neurons in human narcolepsy
- Orexinergic system dysregulation in Alzheimer's disease: a new therapeutic target? *J Alzheimers Dis*
- Reduction of orexin (hypocretin) neurons in multiple system atrophy
- Orexin receptors: pharmacology and therapeutic opportunities
- Orexin-A protects against amyloid-beta-induced oxidative stress and mitochondrial dysfunction in neuronal cells
- Orexin receptor antagonism improves sleep and reduces amyloid-beta in a mouse model of Alzheimer's disease
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.